Jul 12, 2018
Global Fibromyalgia Therapeutics Strategic Business Report 2018: Annual Estimates & Forecasts (2015-2022)
Jun 14, 2018
Vital Motion's Hummingbird: Fibromyalgia Symptom Relief Without the Negative Side Effects
Jun 07, 2018
AcuPlus Pain Cream Helps Eliminate Pain Medication with New and Improved Formula
May 15, 2018
Case Report: Patient with Rheumatoid Arthritis and Fibromyalgia Receives Breakthrough IV Ketamine Infusions With Astounding Success!
Mar 07, 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
Mar 07, 2018
First RNA-Based Blood Test to Detect Fibromyalgia Introduced by Data Science Company IQuity
Mar 02, 2018
AVACEN Medical Celebrates Its Spa & Wellness Division Launch With Celebrities Attending the 90th Academy Awards
Dec 22, 2017
Breakthrough Treatment IV Ketamine Infusions for CRPS, Fibromyalgia, Depression, PTSD, Chronic Lyme, Rheumatoid Arthritis and More Now Covered By Insurance!
Nov 28, 2017
Global Fibromyalgia Market and Competitive Landscape 2017-2025 - Pipeline, Epidemiology, Market Valuations, Sales, Market Forecasts, Product and Market Shares
Oct 25, 2017
Trump Declares Opioid Crisis is a National Emergency
Oct 23, 2017
Frost & Sullivan Recognizes AVACEN Medical for the Innovative AVACEN 100 Designed to Treat Fibromyalgia Widespread Pain
Oct 12, 2017
AVACEN Medical Recipient of Frost & Sullivan's 2017 New Product Innovation Award for Its Fibromyalgia Pain Management Device
Sep 26, 2017
Health Canada Grants the First Class II Medical Device License for Systemically Treating the Widespread Pain Associated With Fibromyalgia
Sep 22, 2017
New Medical Device Successfully Treating Fibromyalgia Pain in the EU
Sep 20, 2017
Global $50+ Bn Pain Management Drugs and Devices Markets to 2022
Aug 24, 2017
AVACEN Medical Introduces a New Concept for Treating Fibromyalgia Widespread Pain to India
Aug 15, 2017
United States Pain Management Therapeutics Market, Patients Volume, and 50 CompanyâEUR(TM)s Pipeline Analysis (By Product, Indication, Phase of Development)
Aug 04, 2017
AVACEN Medical Receives CE (Conformité Européenne) Mark for Increasing Microcirculation and Treating Widespread Fibromyalgia Pain
Aug 01, 2017
Aptinyx Initiates Phase 2 Clinical Studies Evaluating NYX-2925 in Two Chronic Pain Conditions
Jun 07, 2017
Fibromyalgia Pipeline Therapeutics and Drugs Market Review H1 2017